In the present study, we found that TNF-α treatment drove a significant increase in ROS levels in RA-FLS as well as significant upregulation of NLRP3/ASC/pro-caspase-1, and caspase-1 in these cells, consistent with NLRP3 inflammasome activation. Here, CASP1 is linked to rheumatoid arthritis.